August 26, 2021 10:31 AM EDTUpdated 10:59 AM
FDA+
Manufacturing

FDA faults Japan­ese man­u­fac­tur­er with da­ta breach, con­t­a­m­i­nat­ed in­jecta­bles

Josh Sullivan

The FDA has come down hard on a Japan­ese man­u­fac­tur­er, with cGMP fail­ures that in­clude batch dis­crep­an­cies left with­out in­ves­ti­ga­tion, da­ta …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

GSK's Ze­ju­la-Jem­per­li com­bo in ovar­i­an can­cer hits pri­ma­ry end­point, miss­es on over­all sur­vival

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

A service from the Financial Times